Holen Sie sich die Stockscreener-App
13.32
1.68%
0.22
Handel nachbörslich:
13.32
Schlusskurs vom Vortag:
$13.10
Offen:
$13.3
24-Stunden-Volumen:
7,287
Relative Volume:
0.57
Marktkapitalisierung:
$912.62M
Einnahmen:
$277.56M
Nettoeinkommen (Verlust:
$-13.33M
KGV:
-70.11
EPS:
-0.19
Netto-Cashflow:
$-6.54M
1W Leistung:
-0.08%
1M Leistung:
-17.47%
6M Leistung:
+48.66%
1J Leistung:
+56.34%
1-Tages-Spanne:
$13.03
$13.43
1-Wochen-Bereich:
$13.03
$13.84
52-Wochen-Spanne:
$7.31
$17.08
Pharming Group N V Adr Stock (PHAR) Company Profile
Firmenname
Pharming Group N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
13.32 | 897.54M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | Jefferies | Buy |
Pharming Group N V Adr Aktie (PHAR) Neueste Nachrichten
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update - MarketBeat
Pharming Group (PHAR) to Release Earnings on Thursday - Defense World
Pharming Group (NASDAQ:PHAR) Upgraded at Weiss Ratings - Defense World
Pharming Group (NASDAQ:PHAR) Shares Gap DownHere's Why - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Up 9.5%What's Next? - MarketBeat
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Down 71.8% in September - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 64.2% - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.6%What's Next? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Up 7%Still a Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Shares Gap UpTime to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreaseTime to Buy? - MarketBeat
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Still a Buy? - Defense World
Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Pharming Group (NASDAQ:PHAR) Stock Price Down 4.4%What's Next? - MarketBeat
Short Interest in Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Increases By 378.6% - MarketBeat
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Stock Price Up 5%Here's Why - MarketBeat
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus - Zacks Investment Research
Pharming Group appoints Kenneth Lynard as Chief Financial Officer - GlobeNewswire Inc.
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - The Globe and Mail
Pharming Group (NASDAQ:PHAR) Shares Gap Up – Should You Buy? - Defense World
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High? - ca.finance.yahoo.com
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet - Yahoo Finance
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume on Earnings Beat - Defense World
New Strong Buy Stocks for August 1st - TradingView
Pharming Group (NASDAQ:PHAR) Shares Gap Up After Earnings Beat - Defense World
Best Momentum Stocks to Buy for July 25th - TradingView
New Strong Buy Stocks for July 25th - TradingView
New Strong Buy Stocks for July 17th - MSN
Best Momentum Stocks to Buy for July 17th - NewsBreak: Local News & Alerts
PHAR stock hits 52-week high at $11.14 amid robust growth By Investing.com - Investing.com South Africa
PHAR stock hits 52-week high at $11.14 amid robust growth - Investing.com India
Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq
H.C. Wainwright maintains Buy on Pharming with $37 price target - Investing.com
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
What is the current Price Target and Forecast for Pharming Group (PHAR) - Zacks Investment Research
What date does Pharming Group's (PHAR) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Finanzdaten der Pharming Group N V Adr-Aktie (PHAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):